Cytokinetics Inc. buy Citigroup Inc.
Start price
02.09.25
/
50%
€41.80
Target price
02.09.26
€71.78
Performance (%)
29.19%
Price
17.03.26
€54.00
Summary
This prediction is currently active. The prediction currently has a performance of 29.19%. This prediction currently runs until 02.09.26. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Cytokinetics Inc. | -2.703% | -2.703% |
| iShares Core DAX® | -0,44 % | -5,31 % |
| iShares Nasdaq 100 | -0,19 % | 3,08 % |
| iShares Nikkei 225® | -0,95 % | -5,88 % |
| iShares S&P 500 | -0,42 % | 0,92 % |
Comments by Citigroup_Inc_ for this prediction
In the thread Discuss Cytokinetics Inc.
Cytokinetics (NASDAQ:CYTK) had its price target raised by analysts at Citigroup Inc. from $77.00 to $84.00. They now have a "buy" rating on the stock.
Ratings data for CYTK provided by MarketBeat
Stopped prediction by Citigroup_Inc_ for Cytokinetics Inc.
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€29.40
07.05.25
07.05.25
€70.52
07.05.26
07.05.26
83.67%
17.03.26
17.03.26
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€43.80
07.02.25
07.02.25
€82.96
07.02.26
07.02.26
21.00%
08.02.26
08.02.26